Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells

Documenti analoghi

• FGFR1 activation is an escape mechanism in human lung cancer cells resistant to afatinib, a pan-EGFR family kinase inhibitor
  di: Azuma, Koichi, et al.
  Pubblicazione: (2014)
• N-myc Downstream Regulated Gene 1 (NDRG1) Promotes Metastasis of Human Scirrhous Gastric Cancer Cells through Epithelial Mesenchymal Transition
  di: Ureshino, Hiroki, et al.
  Pubblicazione: (2012)
• The activation of SRC family kinases and focal adhesion kinase with the loss of the amplified, mutated EGFR gene contributes to the resistance to afatinib, erlotinib and osimertinib in human lung cancer cells
  di: Murakami, Yuichi, et al.
  Pubblicazione: (2017)
• Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
  di: Matsuo, Norikazu, et al.
  Pubblicazione: (2016)
• Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples
  di: Ishii, Hidenobu, et al.
  Pubblicazione: (2015)